Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
9.96
+0.83 (9.09%)
At close: Oct 3, 2025, 4:00 PM EDT
9.99
+0.03 (0.30%)
After-hours: Oct 3, 2025, 4:55 PM EDT

Anavex Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2015 - 2019
8564825378041,359274
Upgrade
Market Cap Growth
84.77%-10.27%-33.27%-40.83%396.34%64.61%
Upgrade
Enterprise Value
7293433826511,202246
Upgrade
Last Close Price
9.135.686.5510.3217.954.55
Upgrade
PB Ratio
8.574.013.785.659.0110.06
Upgrade
P/TBV Ratio
9.134.013.785.659.0110.06
Upgrade
Quick Ratio
8.898.8012.2714.9214.934.67
Upgrade
Current Ratio
8.938.8612.3214.9514.974.73
Upgrade
Return on Equity (ROE)
-43.64%-32.81%-33.41%-32.71%-42.58%-110.59%
Upgrade
Return on Assets (ROA)
-27.41%-21.81%-21.59%-18.95%-23.87%-55.77%
Upgrade
Return on Capital (ROIC)
-30.30%-24.12%-23.32%-20.31%-26.29%-70.26%
Upgrade
Earnings Yield
-5.80%-8.93%-8.85%-5.96%-2.79%-9.60%
Upgrade
FCF Yield
-4.47%-6.40%-5.18%-3.01%-2.23%-7.77%
Upgrade
Buyback Yield / Dilution
-2.72%-4.61%-3.74%-10.18%-19.95%-18.99%
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q